Acute Myelogenous Leukemia Associated with MLL-SEPT6 Rearrangement and TRAF3, FGFR3 Mutation: A Pediatric Case Report and Review of the Literature

The MLL gene is a site of frequent rearrangement in acute leukemia with multiple fusion partners, but MLL-SEPT6 rearrangement is rare in clinical leukemia practice, and only 13 cases have been reported. We describe the case of an acute myelogenous leukemia child with MLL-SEPT6 rearrangement whose age of onset and accompanying gene mutations differs from previous reports. Considering the poor prognosis of leukemia children with MLL-SEPT6 rearrangement and the unsatisfactory results of existing treatments, the study of this case may provide new theories for diagnosis and treatment of MLL-SEPT6-associated childhood acute leukemia.

[1]  C. So,et al.  Novel therapeutic strategies for MLL-rearranged leukemias. , 2020, Biochimica et biophysica acta. Gene regulatory mechanisms.

[2]  K. Ozono,et al.  Proposal of patient-specific growth plate cartilage xenograft model for FGFR3 chondrodysplasia. , 2018, Osteoarthritis and cartilage.

[3]  E. Clappier,et al.  The MLL recombinome of acute leukemias in 2017 , 2017, Leukemia.

[4]  G. Bishop,et al.  TRAF3 deficiency promotes metabolic reprogramming in B cells , 2016, Scientific Reports.

[5]  G. Bishop,et al.  Nuclear TRAF3 is a negative regulator of CREB in B cells , 2016, Proceedings of the National Academy of Sciences.

[6]  David H Perlman,et al.  Mutated in colorectal cancer (MCC) is a novel oncogene in B lymphocytes , 2014, Journal of Hematology & Oncology.

[7]  H. Hsieh,et al.  CDKN1A‐mediated responsiveness of MLL‐AF4‐positive acute lymphoblastic leukemia to Aurora kinase‐A inhibitors , 2014, International journal of cancer.

[8]  A. Munnich,et al.  FGFR3 mutation causes abnormal membranous ossification in achondroplasia. , 2014, Human molecular genetics.

[9]  O. Williams,et al.  In focus: MLL-rearranged leukemia , 2013, Leukemia.

[10]  M. Teixeira,et al.  Molecular characterization of the MLL-SEPT6 fusion gene in acute myeloid leukemia: identification of novel fusion transcripts and cloning of genomic breakpoint junctions , 2008, Haematologica.

[11]  E. van Binsbergen,et al.  A new subtype of MLL-SEPT2 fusion transcript in therapy-related acute myeloid leukemia with t(2;11)(q37;q23): a case report and literature review. , 2007, Cancer genetics and cytogenetics.

[12]  M. König,et al.  Molecular dissection of t(11;17) in acute myeloid leukemia reveals a variety of gene fusions with heterogeneous fusion transcripts and multiple splice variants , 2006, Genes, chromosomes & cancer.

[13]  M. Teixeira,et al.  SEPT2 is a new fusion partner of MLL in acute myeloid leukemia with t(2;11)(q37;q23) , 2006, Oncogene.

[14]  Steven S. Oh,et al.  MLL-SEPT6 fusion transcript with a novel sequence in an infant with acute myeloid leukemia. , 2006, Cancer genetics and cytogenetics.

[15]  Y. Hayashi,et al.  Disruption of Sept6, a Fusion Partner Gene of MLL, Does Not Affect Ontogeny, Leukemogenesis Induced by MLL-SEPT6, or Phenotype Induced by the Loss of Sept4 , 2005, Molecular and Cellular Biology.

[16]  Hideaki Nakajima,et al.  Dimerization of MLL fusion proteins and FLT3 activation synergize to induce multiple-lineage leukemogenesis. , 2005, The Journal of clinical investigation.

[17]  P. Hall,et al.  The pathobiology of the septin gene family , 2004, The Journal of pathology.

[18]  K Kojima,et al.  FLJ10849, a septin family gene, fuses MLL in a novel leukemia cell line CNLBC1 derived from chronic neutrophilic leukemia in transformation with t(4;11)(q21;q23) , 2004, Leukemia.

[19]  Jen-Fen Fu,et al.  Molecular analysis of t(X;11)(q24;q23) in an infant with AML‐M4 , 2003, Genes, chromosomes & cancer.

[20]  Hee-Jin Kim,et al.  MLL/SEPTIN6 chimeric transcript from inv ins(X;11)(q24;q23q13) in acute monocytic leukemia: Report of a case and review of the literature , 2003, Genes, chromosomes & cancer.

[21]  N. Osheroff,et al.  MLL-SEPTIN6 fusion recurs in novel translocation of chromosomes 3, X, and 11 in infant acute myelomonocytic leukaemia and in t(X;11) in infant acute myeloid leukaemia, and MLL genomic breakpoint in complex MLL-SEPTIN6 rearrangement is a DNA topoisomerase II cleavage site , 2002, Oncogene.

[22]  Y. Hayashi,et al.  SEPTIN6, a human homologue to mouse Septin6, is fused to MLL in infant acute myeloid leukemia with complex chromosomal abnormalities involving 11q23 and Xq24. , 2002, Cancer research.

[23]  A. Borkhardt,et al.  An ins(X;11)(q24;q23) fuses the MLL and the Septin 6/KIAA0128 gene in an infant with AML‐M2 , 2001, Genes, chromosomes & cancer.

[24]  Y. Hayashi,et al.  AF17q25, a putative septin family gene, fuses the MLL gene in acute myeloid leukemia with t(11;17)(q23;q25). , 1999, Cancer research.

[25]  M. Osaka,et al.  MSF (MLL septin-like fusion), a fusion partner gene of MLL, in a therapy-related acute myeloid leukemia with a t(11;17)(q23;q25). , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[26]  E. Rappaport,et al.  t(11;22)(q23;q11.2) In acute myeloid leukemia of infant twins fuses MLL with hCDCrel, a cell division cycle gene in the genomic region of deletion in DiGeorge and velocardiofacial syndromes. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[27]  E. Rappaport,et al.  2 ) in acute myeloid leukemia of infant twins fuses MLL with hCDC rel , a cell division cycle gene in the genomic region of deletion in DiGeorge and velocardiofacial syndromes , 1998 .